These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

837 related articles for article (PubMed ID: 9874455)

  • 41. Occult micrometastases in axillary lymph nodes predict subsequent distant metastases in stage I breast cancer: a case-control study with 15-year follow-up.
    Susnik B; Frkovic-Grazio S; Bracko M
    Ann Surg Oncol; 2004 Jun; 11(6):568-72. PubMed ID: 15150071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
    Hieken TJ; Velasco JM
    Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of axillary lymph node metastasis in T1 breast carcinoma.
    Shoup M; Malinzak L; Weisenberger J; Aranha GV
    Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J; Polgár C; Major T; Németh G
    Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
    Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a,bNOMO): clinicopathologic features and outcome.
    Lee AK; Loda M; Mackarem G; Bosari S; DeLellis RA; Heatley GJ; Hughes K
    Cancer; 1997 Feb; 79(4):761-71. PubMed ID: 9024714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of axillary lymph node involvement in small breast cancer: analysis of 893 cases.
    Cutuli B; Velten M; Martin C
    Clin Breast Cancer; 2001 Apr; 2(1):59-65; discussion 66. PubMed ID: 11899384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy.
    Nixon AJ; Schnitt SJ; Gelman R; Gage I; Bornstein B; Hetelekidis S; Recht A; Silver B; Harris JR; Connolly JL
    Cancer; 1996 Oct; 78(7):1426-31. PubMed ID: 8839547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breast cancer: risk of axillary recurrence in node-negative patients following partial dissection of the axilla.
    Graversen HP; Blichert-Toft M; Andersen JA; Zedeler K
    Eur J Surg Oncol; 1988 Oct; 14(5):407-12. PubMed ID: 3181444
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Relation of tumor size, lymph node status and prognosis in breast cancer].
    Shen ZZ
    Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):554-7, 589. PubMed ID: 1813258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T1a and T1b breast cancer: a twelve-year experience.
    Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
    Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Axillary lymph node dissection: does it have a role in primary breast cancer?
    Pack MS; Thomas RS
    Am Surg; 1996 Feb; 62(2):159-61. PubMed ID: 8554194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
    Chevinsky AH; Ferrara J; James AG; Minton JP; Young D; Farrar WB
    Surgery; 1990 Oct; 108(4):612-7; discussion 617-8. PubMed ID: 2218870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability.
    Silverstein MJ; Gierson ED; Waisman JR; Colburn WJ; Gamagami P
    J Am Coll Surg; 1995 Jun; 180(6):700-4. PubMed ID: 7773483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.
    Schnitt SJ; Hayman J; Gelman R; Eberlein TJ; Love SM; Mayzel K; Osteen RT; Nixon AJ; Pierce S; Connolly JL; Cohen P; Schneider L; Silver B; Recht A; Harris JR
    Cancer; 1996 Mar; 77(6):1094-100. PubMed ID: 8635129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A risk stratification by hormonal receptors (ER, PgR) and HER-2 status in small (< or = 1 cm) invasive breast cancer: who might be possible candidates for adjuvant treatment?
    Park YH; Kim ST; Cho EY; Choi YL; Ok ON; Baek HJ; Lee JE; Nam SJ; Yang JH; Park W; Choi DH; Huh SJ; Ahn JS; Im YH
    Breast Cancer Res Treat; 2010 Feb; 119(3):653-61. PubMed ID: 19957028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.
    Veronesi U; Salvadori B; Luini A; Banfi A; Zucali R; Del Vecchio M; Saccozzi R; Beretta E; Boracchi P; Farante G
    Ann Surg; 1990 Mar; 211(3):250-9. PubMed ID: 2106841
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T1 breast carcinoma in women 70 years of age and older may not require axillary lymph node dissection.
    Feigelson BJ; Acosta JA; Feigelson HS; Findley A; Saunders EL
    Am J Surg; 1996 Nov; 172(5):487-9; discussion 489-90. PubMed ID: 8942550
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
    Djordjevic B; Malpica A
    Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.